Kothari Fermentation & Biochem Intrinsic Value
Kothari Fermentation & Biochem (KFBL) median intrinsic value is ₹59.73 from 4 valuation models (range ₹32–₹68), vs current price ₹40.66 — +46.9% upside (Trading Below Calculated Value), margin of safety 31.9%. For current market price and key ratios, visit KFBL stock live price.
KFBL Valuation Methods Summary — DCF, Graham Number & P/E
Kothari Fermentation & Biochem intrinsic value across 4 models vs current price ₹40.66 — upside/downside and value range per method. Browse KFBL cash flow statement for revenue, profit, balance sheet and cash flow data.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹38.00 | ₹34.20 - ₹41.80 | -6.5% | Book Value/Share: ₹38.00, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹59.73 | ₹53.76 - ₹65.70 | +46.9% | Revenue/Share: ₹74.67, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹32.00 | ₹28.80 - ₹35.20 | -21.3% | EBITDA: ₹8.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹68.08 | ₹54.46 - ₹81.70 | +67.4% | CF Growth: 5.0%, Discount: 15% |
KFBL Intrinsic Value vs Market Price — All Valuation Models
Kothari Fermentation & Biochem fair value range ₹32–₹68 vs current market price ₹40.66 across 4 valuation models. Compare with Kothari Fermentation & Biochem value estimation to assess whether the stock is under or overvalued.
KFBL Intrinsic Value Analysis — Undervalued or Overvalued?
Kothari Fermentation & Biochem median intrinsic value ₹59.73, current price ₹40.66 — Trading Below Calculated Value by 46.9%, margin of safety 31.9%.
What is the intrinsic value of KFBL?
Based on our comprehensive analysis using 4 different valuation methods, the estimated intrinsic value of Kothari Fermentation & Biochem (KFBL) is ₹59.73 (median value). With the current market price of ₹40.66, this represents a +46.9% variance from our estimated fair value.
The valuation range spans from ₹32.00 to ₹68.08, indicating ₹32.00 - ₹68.08.
Is KFBL undervalued or overvalued?
Based on our multi-method analysis, Kothari Fermentation & Biochem (KFBL) appears to be trading below calculated value by approximately 46.9%.
KFBL Financial Health — Key Ratios vs Industry Benchmarks
Kothari Fermentation & Biochem financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 0.90 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Return on Equity | -7.0% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 7.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.88x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
KFBL Cash Flow Quality — Operating & Free Cash Flow
Kothari Fermentation & Biochem operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹11 Cr | ₹9 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹9 Cr | ₹6 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹6 Cr | ₹5 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹10 Cr | ₹4 Cr | Positive Free Cash Flow | 7/10 |
| March 2021 | ₹15 Cr | ₹7 Cr | Positive Free Cash Flow | 7/10 |